Cargando…
Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of Mice
Influenza virus M2 extracellular domain (M2e) has been a target for developing cross-protective vaccines. However, the efficacy and immune correlates of M2e vaccination are poorly understood in the different host genetic backgrounds in comparison with influenza vaccines. We previously reported the c...
Autores principales: | Kim, Yu-Jin, Lee, Young-Tae, Kim, Min-Chul, Lee, Yu-Na, Kim, Ki-Hye, Ko, Eun-Ju, Song, Jae-Min, Kang, Sang-Moo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727122/ https://www.ncbi.nlm.nih.gov/pubmed/29276514 http://dx.doi.org/10.3389/fimmu.2017.01730 |
Ejemplares similares
-
Virus-Like Particles Are a Superior Platform for Presenting M2e Epitopes to Prime Humoral and Cellular Immunity against Influenza Virus
por: Kim, Ki-Hye, et al.
Publicado: (2018) -
Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses
por: Lee, Young-Tae, et al.
Publicado: (2018) -
New vaccines against influenza virus
por: Lee, Young-Tae, et al.
Publicado: (2014) -
Divalent cation-induced conformational changes of influenza virus hemagglutinin
por: Seok, Jong Hyeon, et al.
Publicado: (2020) -
Conformational modulation of influenza virus hemagglutinin: characterization and in vivo efficacy of monomeric form
por: Seok, Jong Hyeon, et al.
Publicado: (2017)